Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Binhai Meikang Pharmaceutical is a Chinese pharmaceutical company based in Binhai County, Jiangsu Province, specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a strong focus on central nervous system (CNS) therapeutics, producing a variety of sedative-hypnotics, antidepressants, and antipsychotics. With a significant manufacturing footprint, Binhai Meikang operates GMP-certified facilities that supply both domestic and international markets. Their business model integrates chemical synthesis with pharmaceutical formulation to ensure a stable supply chain for essential psychiatric and neurological medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Binhai Meikang Pharmaceutical.